Asthma - Short-Acting Beta Agonist Inhaler for Rescue Therapy
-
The percentage of patients 2 years or older with asthma who have a refill for a short-acting beta agonist in the past 12 months.
CBE ID0620
The percentage of patients 2 years or older with asthma who have a refill for a short-acting beta agonist in the past 12 months.
The percentage of patients aged 12 years and older with coronary artery disease, or 18 years and older with cerebrovascular disease or peripheral vascular disease that have been screened for dyslipidemia with a lipid profile
The percentage of patients aged 18 and older with a diagnosis of atherosclerotic disease whose most recent LDL-C value is greater than 100 mg/dL and who are taking a lipid lowering agent
Percentage of adult patients aged 25 and older with atrial fibrillation and major stroke risk factors who are on anticoagulation therapy.
The percentage of patients with chronic kidney disease that have been screened for dyslipidemia with a lipid profile.
The percentage of patients with chronic kidney disease stage 5 and an LDL greater than or equal to 130 mg/dl that have a current refill for a lipid lowering agent.
The percentage of adult patients with chronic liver disease who have received a hepatitis A vaccine
The percentage of patients age 18 years or older with poorly controlled COPD, who are taking a long acting bronchodilator.
Percentage of patients 40 years and older with COPD exacerbations that are receiving a long acting bronchodilator
The percentage of patients aged 18 to75 years with a diagnosis of diabetes whose most recent HbA1c value is between 8 and 10 percent and who are taking metformin.